The oncogenic proteins encoded by papovaviruses, the tumor antigens, have been extensively used as model systems to study mitogenic signaling and cell transformation. These proteins stimulate cell growth in cultured cells and induce tumors in virus infected or transgenic animals. One of these proteins, polyomavirus middle-T, acts like a constitutively activated tyrosine growth factor receptor. Middle-T recruits several cellular enzymes into a multifunctional complex located at cellular membranes. This results in the activation of cellular enzymes involved in the regulation of cell signaling, like tyrosine kinases of the Src family, a phosphatidylinositol 3-kinase and a GDP/GTP exchange factor for Ras. These activities are all required for stimulation of cell growth by middle-T and activate members of the MAP kinase family. Here we investigate the role of T antigen-activated pathways in the stimulation of transcription of immediate early genes. These genes are essential for progression of resting cells into S phase. Our data show that Rho family GTPases play an essential role in cell transformation by middle-T. Furthermore, we demonstrate that the c-fos promoter is activated by two Ras-initiated signaling cascades. One is Raf-dependent and requires binding of SHC and PI 3-kinase to the middle-T complex. This pathway signals via ternary complex factor (TCF) to the serum response element (SRE) of the c-fos promoter. Signaling to TCF by Raf also depends on functional Rac, but not CDC42, as demonstrated in luciferase reporter assays with an ETS domain-containing promoter. The second pathway is Raf-independent, does not require SHC but functional PI 3-kinase, and transduces signals via Rac to serum response factor (SRF). Microinjection of dominant negative Rac1 blocks nuclear translocation of ERK1 in middle-T-expressing cells. This lends support to the idea that the two signaling cascades initiated by Ras show crosstalk at the level of MAP kinase-mediated signaling to nuclear transcription factors.
Introduction
DNA tumor viruses have been extensively used as model systems to study mitogenic stimulation in a variety of cell types. Several viral proteins have been discovered in recent years that are able to target the cellular network regulated by growth factors like PDGF, CSF-1, EGF, IGF etc, in normal cells. Polyomaviruses express three proteins, small-, middleand large-tumor antigen (small-T, Middle-T, large-T) early in their viral life cycle that target the cellular machinery regulating cell growth. These proteins induce tumors in virus infected animals and transform cells in culture (reviewed in Tooze, 1980; Nevins, 1994; Moran, 1993) . Middle-T is sucient to cause tumors when expressed in transgenic mice and transforms established mouse and rat ®broblasts (reviewed in Dilworth, 1995) . Both middle-and large-T are required for oncogenic transformation of primary cells by polyomavirus (Rassoulzadegan et al., 1982) . The activity of middle-T is a consequence of its ability to bind to and thereby activate a variety of cellular signaltransducing proteins. Members of the Src family of tyrosine kinases (c-Src, Fyn and c-Yes) (reviewed in Dilworth, 1995; Courtneidge, 1986 ) associate with middle-T and phosphorylate this protein at tyrosine residues. The phosphotyrosines act as docking sites for SH2 and PTB domain-binding cellular proteins like the lipid kinase phosphatidylinositol 3-kinase (PI 3-kinase) (Whitman et al., 1985) , the adaptor protein SHC Campbell et al., 1994) and phospholipase C-g1 (PLC-g1) (Su et al., 1995) . In addition, the serine/threonine speci®c phosphatase 2A (PP2A) (Walter et al., 1990; Pallas et al., 1990 ) and a member of the 14-3-3 family of proteins have been found to associate with middle-T. PP2A, a ubiquitously expressed cellular phosphatase, is also known to bind to SV40 or polyoma small-T and has been shown to interfere with downregulation of ERK1 and ERK2 (Sontag et al., 1993; Frost et al., 1994) . C-Src as well as 14-3-3 have been implicated in the activation of Raf (Marais et al., 1995; Freed et al., 1994; Irie et al., 1994; Fu et al., 1994; Li et al., 1995) .
We have shown recently that expression of middle-T in rat and mouse ®broblasts leads to sustained activation and nuclear translocation of the mitogen activated protein kinase (MAP kinase) isoform ERK1. Activation involves the well established signaling cascade initiated by SHC, Grb2 and SOS resulting in stimulation of Ras. This leads to the activation of Raf and the MAP kinase kinase MEK. We have also shown that PI 3-kinase activation by middle-T is essential for nuclear translocation of ERK1 .
These data left us with the question whether sustained activation and nuclear translocation of ERKs are sucient to account for cell transformation by middle-T. The use of constitutively activated or catalytically inactive MEK mutants suggests that activation of the ERK cascade is indeed both necessary and sucient for cell transformation (Cowley et al., 1994; Mansour et al., 1994) . On the other hand, the eector domain mutant V12S35HaRas, which fully stimulates ERK activity, is compromised in its transforming capacity, suggesting that additional HaRas eectors, like e.g. small GTPases of the Rho family, contribute to cell transformation and mitogenesis (Joneson et al., 1996) . The small GTPases Rac1, Rho and CDC42 have also been identi®ed as crucial mediators of Ras-dependent cellular responses and seem to cooperate with Raf in cell transformation (Qiu et al., 1995a) . Rac1 regulates membrane ruing through formation of cortical actin ®bers , whereas Rho controls formation of stress ®bers . CDC42 was found to be involved in ®lopodia formation (Nobes and Hall, 1995) . Rac1 and CDC42 are also important in the activation of Jun kinase (JNK) regulating a pathway parallel to the ERK cascade (Minden et al., 1995; Coso et al., 1995) . Rho, Rac1 and CDC42 play a crucial role in the activation of the c-fos promoter by activating serum response factor (SRF) and are known to cooperate with Raf in cell transformation assays (Qiu et al., 1995a,b) . More recently, it has been shown, that expression of activated versions of Rho, Rac1 and CDC42 are sucient to induce cell cycle progression through G 1 (Olson et al., 1995) .
In this report we demonstrate a crucial function for Rac1 and CDC42 in polyomavirus middle-T-induced cell transformation. We further show that activation of the c-fos promoter by middle-T requires functional Rac1 and bifurcates at the level of Ras into a Rafdependent and a Raf-independent pathway. We also provide evidence that middle-T-induced activation of TCF requires functional Rac1. This might be explained by the observation that nuclear translocation of ERK1 upon middle-T expression is blocked by dominant negative forms of Rac1.
Results
The dominant negative alleles V12N17rac1 and N17CDC42 inhibit focus formation by middle-T in F111 rat ®broblasts It is well established that expression of middle-T in mouse or rat ®broblasts leads to constitutive activation of Ras and that this function correlates with the tumorigenic potential of middle-T (Srinivas et al., 1994; Jelinek and Hassell, 1992) . In order to test whether the recently described Ras eectors Rac1 and CDC42 are involved in middle-T-induced cell transformation, we cotransfected expression vectors carrying the dominant negative alleles V12N17rac1 or N17CDC42 together with a middle-T-encoding expression plasmid into F111 rat ®broblasts. We subsequently investigated the ability of the transfected cells to grow to high density under low serum conditions in focus formation assays. While the empty vector had no eect on focus formation, coexpression of V12N17rac1 or N17CDC42 completely blocked the transforming potential of middle-T. Coexpression of wild type Rac1 and CDC42 did not aect focus formation by middle-T (Table 1) . We found no eect of V12N17rac and N17CDC42 on the growth rate of F111 cells when testing colony formation under G418 selection (data not shown). From these experiments we conclude that the small GTPases Rac1 and CDC42 play an essential role in middle-T-induced cell transformation.
Middle-T-induced activation of the c-fos promoter is blocked by V12N17rac1 but not by N17CDC42 Activation of receptor tyrosine kinases stimulates a signaling cascade involving transient formation of Ras/ GTP and activation of the Raf kinase at the plasma membrane. This is followed by sequential activation of MEK and ERK1/ERK2, which then enters the nucleus. A well described nuclear target of this pathway is the c-fos promoter. We previously demonstrated that middle-T uses a similar mechanism to activate transcription from various promoters . Furthermore, it has been shown that Rho, Rac1, and CDC42 are involved in transcriptional activation of the serum response element (SRE) . We therefore addressed the question whether Rac1 and CDC42 mediate middle-T-induced transcriptional activation. The coding sequence of the luciferase gene under the control of the human c-fos promoter (foslux) was used as a reporter system. Signaling intermediates responsible for the induction of transcription were identi®ed by transiently transfecting foslux together with middle-T and the dominant negative alleles N17ras, NDel.raf, V12N17rac1 and N17CDC42 into NIH3T3 cells. The constitutively activated alleles L61Ras and two forms of activated Raf, BXBRaf and CaaxRaf (data not shown) were used as positive controls. As shown in Figure 1 , middle-T induces foslux approximately eightfold, which is in the range of the induction by BXBraf. In agreement with our earlier published data, both dominant negative forms of Ras (N17Ras) and Raf (Ndel.Raf) completely blocked transcriptional activation by middle-T. Interestingly, expression of V12N17Rac1 also blocked middle-T-induced foslux transcription to baseline levels. Despite its strong eect on middle-T-induced focus formation, N17CDC42 did not inhibit signaling to foslux. The empty vector, wild type Rac1 and wild type CDC42 had no eect on foslux activation by middle-T. From these data we conclude that Rac1 and CDC42 perform dierent functions in cell transformation by middle-T.
Middle-T-induced signaling to the nucleus bifurcates at the level of Ras
The SRE is the major regulatory element of the c-fos promoter. SRE binds the ubiquitous transcription factor SRF (Norman et al., 1988) and forms a ternary complex with TCF (ternary complex factor), which cannot bind SRE by itself (Shaw et al., 1989) . TCF is a representative of the ETS domain protein family including Elk-1, SAP-1 and SAP-2 and is sensitive to signals emanating from the Ras/Raf/ERK-pathway (Hill et al., 1993; Kortenjann et al., 1994; Janknecht et al., 1995) . Transcriptional activation of the c-fos promoter through SRF, on the other hand, has been shown to be regulated by Rho, Rac1 and CDC42 .
Given the observation that functional Rac1 is necessary for foslux induction by middle-T, we wanted to identify the signaling pathways that link middle-T to Rac1-dependent c-fos promoter activation. We ®rst asked whether Rac1 contributes to the earlier described activation of the Ras/Raf/ERK-pathway by middle-T (Urich et al., 1995). We took advantage of the fact, that the activation of the dierent elements of the c-fos promoter can be studied individually in transient transfection assays using various reporter systems.
GalElk is a derivative of TCF/Elk-1 in which the ETS box DNA-binding domain has been replaced by that of the yeast transcription factor Ga14. GalElk binds with high anity to G5E4lux, a yeast E4 promoter with ®ve Gal4 binding sites upstream of the luciferase coding sequence. Transcriptional activation by GalElk is regulated by phosphorylation at MAP kinase consensus sites (Kortenjann et al., 1994) . The GalElk/G5E4lux system therefore provides a tool to measure activation of the Ras/Raf/ERK pathway.
To study the eect of Rac1 on middle-T-induced cfos promoter activation independently of the Ras/Raf/ ERK pathway we used the reporter plasmid DSElux, consisting of a mutant c-fos SRE, which does not bind TCF, upstream of an Ad2 E4 TATA box.
As shown in Figure 2A , cotransfection of a middle-T expression plasmid with GalElk/G5E4lux resulted in 30-to 40-fold activation of transcription. The eect of constitutively active BXBRaf in this system was in the same range. Expression of the activated L61Ras led to signi®cantly higher activation. Transcriptional activity induced by middle-T was blocked completely upon cotransfection with the dominant negative alleles N17Ras and NDel.Raf. As a control, NDel.Raf but not N17Ras completely blocked L61Ras-induced activity. BXBRaf-induced luciferase synthesis was not aected by N17Ras as expected (data not shown) but was increased by NDel.Raf for unknown reasons.
Interestingly, cotransfection of the dominant negative mutant V12N17Rac1 also reduced transcriptional activation by middle-T, L61Ras, and BXBRaf in the GalElk/G5E4lux system. To rule out the possibility that GalElk phosphorylation was the consequence of the activation of a parallel pathway activating JNK, we performed similar experiments with GalSAP-1 as transcriptional activator that is not phosphorylated by JNK (Shaw et al. Manuscript in preparation) . Figure 2B shows that middle-T activates Gal-Sap1 but not a mutant where serine 383 was mutated to alanine. Both V12N17Rac as well as NDel.Raf (not shown) blocked activation of the G5E4 promoter in this experimental setup. Figure 3 shows transient transfection experiments with the plasmid DSElux. In agreement with recently published data we show that the activated mutant V12Rac stimulates transcription from DSE. We found that L61Ras as well as middle-T expression resulted in strong activation of DSElux. The constitutively activated allele BXBRaf was inactive in this assay. Cotransfection of middle-T with V12N-17Rac1 blocked activation of DSElux, suggesting that middle-T activates transcription from the c-fos SRF binding element in a Rac-dependent manner. Similarly, N17Ras blocked middle-T-mediated DSElux activation, but did not aect signaling initiated by V12Rac (data not shown). L61Ras-induced activity was slightly decreased by cotransfection of N17Ras. Coexpression of NDel.Raf had no eect on middle-T-induced transcriptional activity from DSElux, showing that Raf is not part of this pathway. Taken together, these data suggest that signaling of middle-T to the c-fos promoter bifurcates at the level of Ras. A Raf-dependent pathway signals via MAP kinase to TCF, whereas a Raf-independent, but Rac1-dependent signaling cascade, leads to TCF-independent transcriptional activation.
SHC binding to middle-T is necessary for ecient signaling via the MAP kinase cascade, but is not required for Rac1-dependent transcriptional activation
Middle-T is found in complexes with a variety of cellular signal transduction molecules. We were interested in the association of middle-T with SHC and PI 3-kinase, since these proteins might link Tantigen signaling to the activation of Ras. SHC is a catalytically inactive adapter protein selectively binding to phosphorylated growth factor receptors resulting in its tyrosine phosphorylation ). Tyrosine phosphorylated SHC can then bind the cytoplasmic Grb2/SOS complex via the SH2 domain of Grb2 promoting GDP/GTP exchange and activation of Ras (Rozakis-Adcock et al., 1992; . Similarly, middle-T activates Ras by associating with SHC through tyrosine 250 Campbell et al., 1994) . Both SHC and PI 3-kinase are required for T antigen-mediated transformation reminiscent of studies with tyrosine growth factor receptors (reviewed in Kapeller and Cantley, 1994; Varticovski et al., 1994) . In recent reports several groups provided evidence for an interaction between PI 3-kinase and Ras. Constitutively active catalytic subunits of PI 3-kinase activate Ras (Hu et al., 1995) and activated mutants of Ras increase the production of PI 3-kinase products in vivo, suggesting that these pathways work in both directions (Rodriguez-Viciana et al., 1994) .
We investigated whether binding of SHC and PI 3-kinase to middle-T contributes to both Raf-and Rac1-mediated c-fos promoter activation and took advantage of the middle-T mutants Y250F and Y315FmT. These mutants lack the tyrosine residues responsible for SHC and PI 3-kinase binding, respectively. As shown in Figure 4 , activation of GalElk/G5E4lux was signi®cantly lower in Y250FmT and Y315FmT compared with wild type middle-T-expressing cells. Middle-T-induced transcriptional activity was blocked by treatment with 15 mM of the selective PI 3-kinase inhibitor LY294002. This shows that PI 3-kinase activity is required for ecient signaling of middle-T via the ERK pathway . A much smaller reduction was observed upon coexpression of middle-T with the kinase dead PI 3-kinase mutant R916Pp110 that was expected to act as a dominant negative allele.
Activation of DSElux showed a dierent pattern ( Figure 5 ). Whereas Y315FmT was signi®cantly impaired in its signaling capacity, Y250FmT activated DSElux as eciently as wild type middle-T. Middle-Tinduced activity could be blocked by cotransfection with the dominant negative catalytic subunit of PI 3-kinase and by treatment with LY294002.
Taken together these data indicate that PI 3-kinase is required for both TCF as well as SRF-mediated signaling to the c-fos promoter by middle-T, yet the pathways activated upstream from Ras dier. Figure 2 open the possibility of crosstalk between the Ras/Raf/ERK pathway and Rac1-mediated signaling to the c-fos promoter. We were therefore interested whether V12N17Rac1 influences signaling of middle-T via ERKs. A stringent assay to test for ecient activation of ERKs by mitogenic stimuli is to check whether these kinases accumulate in the nucleus. We microinjected a middle-T-encoding expression plasmid alone and together with a vector expressing the dominant negative mutant V12N17Rac1 into serum-starved Ref 52 cells. Five hours after injection cells were immunostained against middle-T and ERK1. A quanti®cation of the results is shown in Table 2 . Microinjection of middle-T alone led to nuclear translocation of ERK1 in 86% of the middle-T-expressing cells as reported earlier. In cells coinjected with V12N17Rac, middle-T-induced nuclear translocation of ERK1 was reduced to background level. As a control, we coinjected the wild type gene of rac1 which showed no eect on middle-T-induced nuclear translocation of ERK1.
Discussion
Middle-T transforms cells through association with a variety of proteins involved in cell signaling (reviewed in Dilworth, 1995) and thereby interferes with the regulation of cell growth and morphology. In our recent work we demonstrated that one of the major targets of middle-T is the Ras/Raf/ERK pathway. Here we report a crucial function for Rho family small GTPases in middle-T-induced signaling to the c-fos promoter and in cell transformation.
A variety of functions have been ascribed to Rholike proteins that might contribute to cell transformation by middle-T. Both Rac1 and CDC42 are regulated by Ras and organize the cytoskeleton by coordinating the assembly of actin ®laments. The actin cytoskeleton plays a pivotal role in cell motility, cytokinesis, phagocytosis, gene regulation and intracellular transport. Rac1 regulates membrane ruing while CDC42 is necessary for ®lopodia formation (Nobes and Hall, 1995) . Rac1 and CDC42 are also involved in cell signaling to the nucleus in response to growth factors and polypeptide hormones (Minden et al., 1995; Coso et al., 1995) and in regulating cell growth (Olson et al., 1995; Qiu et al., 1995a,b) . We used middle-T as a model system to study signaling in ®broblasts and investigated the role of small Rho family GTPases in the activation of the c-fos promoter. Our observation that both dominant negative CDC42 and Rac1 block focus formation by middle-T, but only the latter had an eect on c-fos activation, point to distinct functions of these proteins in middle-Tdependent signaling and cell transformation. This is an extension of an earlier study that showed that both CDC42 and Rac1 activate SRF resulting in stimulation of the c-fos promoter . Either CDC42 or Rac1 are sucient for induction of the c-fos promoter while both proteins have to be activated to allow for cell transformation by middle-T. Figure 6 schematically shows the signaling pathways leading from middle-T to the c-fos promoter. The order of the signaling cascade was determined using de®ned luciferase promoter constructs and a series of dominant negative or constitutively active signaling intermediates. The TCF binding site has been demonstrated to be the MAP kinase responsive element (Shaw et al., 1989; Treisman, 1994) , whereas the SRF binding site was shown to respond to signals mediated by Rho family G proteins . We used the recently described GalElk/G5E4lux system to activate TCF in the absence of an SRF binding site and the reporter DSElux to monitor SRF activation. Activation of GalElk/G5E4lux by middle-T was strictly dependent on functional Ras, Raf and PI 3-kinase. This is in agreement with our recently published data demonstrating that middle-T activates ERKs in a PI 3-kinase-dependent manner . The ®nding that dominant negative Rac1 reduced activation of GalElk/G5E4lux by middle-T was more surprising because several groups have shown that activation of Rac1 does not interfere with stimulation of ERKs (Minden et al., 1995; Coso et al., 1995; . A possible interpretation might arise from the fact that the GalElk/G5E4lux reporter might also be activated by the JNK cascade which is Rac-dependent. However, several observations argue against the involvement of JNK in this signaling cascade: (i) GalElk/G5E4lux activation was also blocked by dominant negative Rac1 when cells were stimulated by constitutively active Raf (BXBRaf or CaaxRaf) which do not activate JNK (Minden et al., 1994) ; (ii) dominant-negative Raf completely blocked the ability of middle-T to activate GalElk/G5E4lux, con®rming that the pathway is ERK-and not JNKdependent; (iii) the fact that a TCF homolog of Elk, Sap-1, which is not activated by JNK, still responded to middle-T, further proves that ERKs and not JNK are activated by T antigen ( Figure 2B ). Alternatively, transcriptional activation of the reporter G5E4lux by the chimeric transcription factor GalElk might depend on SRF. This model would imply that a ternary complex consisting of Elk, SRF and the G5E4lux promoter forms in the absence of an SRF binding site. This concept was not con®rmed by gel shift data (P Shaw, unpublished) . Finally, inhibition of the GalElk/ G5E4lux reporter in the presence of dominant negative Rac1 could arise as a consequence of crosstalk between the Ras/Raf/MEK/ERK and an unknown Racmediated signaling pathway. Our data suggest that crosstalk occurs at the level of MEK or ERK. Based on earlier published data we tested this possibility and found that dominant negative Rac1 completely blocked nuclear translocation of ERK1 by middle-T. This observation is not necessarily in contradiction to other reports showing that the activity of ERKs is independent of Rac1 (Minden et al., 1995; Coso et al., 1995; since phosphorylation of ERK by MEK is not sucient for nuclear translocation (Traverse et al., 1992) .
Activated Rac (V12Rac) stimulates SRF independently of TCF. The data clearly show that V12Rac1, activated Ras (L61Ras) and middle-T induced DSElux. Neither activated (BXBRaf or CaaxRaf) nor dominant negative mutants of Raf (NDel.Raf) had an eect on DSElux activity. Expression of dominant negative PI 3-kinase or treatment with LY294002 blocked T-antigen medited activation of DSElux. The role of PI 3-kinase in signaling to DSElux was also con®rmed using a middle-T mutant unable to activate PI 3-kinase, Y315FmT. This mutant was defective in activating DSElux. Y250FmT unable to associate with SHC, on the other hand, fully activated DSElux. These data underline the crucial function of PI 3-kinase in middle-T signaling and corroborate the ®nding that cell transformation requires activation of SHC-and of PI 3-kinase-mediated pathways.
Our data imply that middle-T activates Ras via at least two distinct mechanisms with separable signal output ( Figure 6 ): SHC-mediated Ras activation leads to stimulation of the ERK pathway. A subpopulation of Ras, activated by a dierent, not yet identi®ed signaling cascade, signals through Rac1 to SRF. A good candidate for a middle-T-associated molecule mediating Ras activation in this cascade is PI 3-kinase (Hu et al., 1995) . Taken together these data suggest that signal output might not only be determined by which enzymes are activated by a particular stimulus, but also by how and where in the cell a certain signaling molecule has been activated. Future experiments will address the question how activation of PI 3-kinase by middle-T modulates Rac-dependent signaling and why SHC-mediated signaling to Ras results in a dierent, Raf-dependent, signal output.
Materials and methods

Materials
Restriction enzymes were purchased from Boehringer Mannheim. Micro BCA assays were from Pierce and Luciferin was obtained from Chemie Brunschwig AG.
Cell lines
NIH3T3 and Fisher rat embryo F111 ®broblasts were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% calf serum at 378C in a humidi®ed CO 2 incubator. Ref 52 cells were kept in 10% fetal calf serum.
Plasmid constructs
The middle-T and Raf and Ras expression vectors have been described earlier Besser et al., 1995) . The plasmids pEXV.V12rac1 and pEXV.V12N17rac1, encoding myc-tagged constitutively activated and dominant negative versions of the rac1 gene, respectively, were obtained from A Hall . The dominant negative mutant N17CDC42 was also obtained from A Hall. Foslux was generated by cloning the 711bp EcoRI/XhoI fragment into pGL2basic. PSG-GalElk was described earlier (Kortenjann et al., 1994) . G5E4lux was derived from G5E4-38CAT by cloning the PstI fragment into pAH1409 (Kortenjann et al., 1994) . The Caaxraf expression plasmid was obtained from Dr Chr Marshall (Leevers et al., 1994) . Transient transfections and analysis of reporter gene expression NIH3T3 cells were transfected and luciferase activity analysed as described earlier with the only modi®cation, that the cells were starved in 0.1% calf serum after the glycerol shock.
Microinjection of Ref 52 cells and immuno¯uorescence
Ref 52 cells were microinjected using an Eppendorf 5171 micromanipulator and an Eppendorf 5242 microinjection device as described (Messerschmitt et al., 1996) . Localization of ERK1 and detection of middle-T expression in Ref 52 cells was performed as described 5 h after injection of the DNA.
